EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+8.64%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.44B
AUM Growth
+$7.44B
(+10%)
Cap. Flow
+$500M
Cap. Flow
% of AUM
6.72%
Top 10 Holdings %
Top 10 Hldgs %
25.63%
Holding
170
New
15
Increased
63
Reduced
24
Closed
16
Top Buys
| 1 |
Zymeworks
ZYME
|
$62.5M |
| 2 |
nCino
NCNO
|
$39.7M |
| 3 |
Shoals Technologies Group
SHLS
|
$37.4M |
| 4 |
Generac Holdings
GNRC
|
$36M |
| 5 |
argenx
ARGX
|
$35.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$52M |
| 2 |
Verisk Analytics
VRSK
|
$37M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$25.4M |
| 4 |
Okta
OKTA
|
$23.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 29.25% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 7.52% |
| 5 | Communication Services | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$146B
| $96.9M | 1.3% |
499,400
-20,000
| -4% | -$3.88M |
|
27
Waste Connections
WCN
$46.5B
| $96M | 1.29% |
804,000
| – | – |
|
28
D.R. Horton
DHI
$51.3B
| $95.4M | 1.28% |
1,055,493
-7,400
| -0.7% | -$669K |
|
|
TRIL
29
DELISTED
Trillium Therapeutics Inc.
TRIL
| $92.2M | 1.24% |
9,510,000
+1,851,000
| +24% | +$18M |
|
30
Sprout Social
SPT
$896M
| $90.5M | 1.22% |
1,011,920
+1,000
| +0.1% | +$89.4K |
|
31
Trex
TREX
$6.41B
| $90.1M | 1.21% |
882,000
| – | – |
|
|
RXDX
32
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $88.2M | 1.18% |
3,714,032
| – | – |
|
33
RingCentral
RNG
$2.74B
| $87.9M | 1.18% |
302,608
+81,500
| +37% | +$23.7M |
|
|
KRTX
34
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $85.3M | 1.15% |
748,000
-223,077
| -23% | -$25.4M |
|
35
Aptiv
APTV
$17.3B
| $84.5M | 1.13% |
537,000
| – | – |
|
36
Entegris
ENTG
$12B
| $80.1M | 1.08% |
651,599
+35,500
| +6% | +$4.37M |
|
37
Magna International
MGA
$12.7B
| $75.6M | 1.02% |
815,600
-32,400
| -4% | -$3M |
|
38
Pliant Therapeutics
PLRX
$105M
| $72M | 0.97% |
2,471,892
| – | – |
|
39
Celldex Therapeutics
CLDX
$1.57B
| $70.5M | 0.95% |
2,108,908
+46,475
| +2% | +$1.55M |
|
40
ESSA Pharma
EPIX
$11.2M
| $68.7M | 0.92% |
2,405,169
| – | – |
|
41
Praxis Precision Medicines
PRAX
$980M
| $67.7M | 0.91% |
252,470
+18,265
| +8% | +$4.9M |
|
42
Yeti Holdings
YETI
$2.84B
| $63.4M | 0.85% |
690,000
| – | – |
|
43
Collegium Pharmaceutical
COLL
$1.25B
| $62.2M | 0.84% |
2,629,593
+201,617
| +8% | +$4.77M |
|
44
Crown Castle
CCI
$42.3B
| $61.1M | 0.82% |
313,100
-900
| -0.3% | -$176K |
|
45
Vital Farms
VITL
$2.2B
| $60M | 0.81% |
3,008,232
| – | – |
|
46
Palo Alto Networks
PANW
$128B
| $55.4M | 0.74% |
896,022
+600
| +0.1% | +$37.1K |
|
47
TSMC
TSM
$1.2T
| $54.4M | 0.73% |
453,100
| – | – |
|
48
Annexon
ANNX
$225M
| $53.3M | 0.72% |
2,409,166
+404,550
| +20% | +$8.96M |
|
|
49
Shoals Technologies Group
SHLS
$1.13B
| $51.4M | 0.69% |
1,447,460
+1,054,904
| +269% | +$37.4M |
|
50
Datadog
DDOG
$46.2B
| $50.5M | 0.68% |
485,104
+14,201
| +3% | +$1.48M |
|